Form 4: Guardant Health Chief Technology Officer Receives Stock Options and Restricted Stock Units

Darya Chudova, Chief Technology Officer of Guardant Health, was granted stock options and restricted stock units on November 8, 2024, as part of her compensation.

Summary

• Darya Chudova, the Chief Technology Officer of Guardant Health, received stock options for 59,534 shares and 39,689 restricted stock units on November 8, 2024.
• The stock options have an exercise price of $28.61 and vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting monthly over the following two years.
• The restricted stock units also vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting quarterly over the following two years.
• Both the stock options and restricted stock units were granted as part of her compensation package.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The grant of stock options and restricted stock units aligns the Chief Technology Officer's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.
• The awards are part of a standard compensation package for a key executive.

Industry Context

The granting of stock options and restricted stock units is a common practice in the biotechnology industry to attract and retain key talent.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard practice for executive compensation in the biotech industry, similar to companies like Illumina, Exact Sciences, and Myriad Genetics.
• The vesting schedule of three years with a cliff at one year followed by monthly or quarterly vesting is also typical for these types of awards.
• The specific number of shares and units granted would be dependent on the executive's role and the company's overall compensation strategy, which is not detailed in this document.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning management interests with company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, vesting, Guardant Health, Darya Chudova, Chief Technology Officer